Consolidated Statements of Earnings - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Net revenues (Notes 5 & 11)	[1],[2]	$ 40,648	$ 37,878	$ 35,174
Cost of sales		13,366	13,329	12,893
Gross profit		27,282	24,549	22,281
Marketing, administration and research costs (Notes 3, 4, 11 & 18)		12,349	11,147	10,060
Impairment of goodwill (Note 4)		41	0	665
Operating income		14,892	13,402	11,556
Interest expense, net (Note 13)		966	1,143	1,061
Pension and other employee benefit costs (Note 12)		46	60	45
Earnings before income taxes		13,880	12,199	10,450
Provision for income taxes (Note 10)		2,737	3,017	2,339
Impairment related to the RBH equity investment (Note 5)		0	2,316	0
Equity investments and securities (income)/loss, net		(705)	(637)	(157)
Net earnings		11,848	7,503	8,268
Net earnings attributable to noncontrolling interests		500	446	455
Net earnings attributable to PMI		$ 11,348	$ 7,057	$ 7,813
Per share data (Note 9):
Basic earnings per share (in dollars per share)		$ 7.27	$ 4.53	$ 5.02
Diluted earnings per share (in dollars per share)		$ 7.26	$ 4.52	$ 5.02

[1] Includes net revenues from related parties of $4,582 million, $3,876 million and $3,553 million for the years ended December 31, 2025, 2024 and 2023, respectively

[2] Net revenues are shown net of excise tax on products. For the years ended December 31, 2025, 2024 and 2023, excise tax on products was $53,211 million, $51,563 million and $49,404 million, respectively